484 related articles for article (PubMed ID: 30684890)
1. Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity.
Chen X; Xue H; Fang W; Chen K; Chen S; Yang W; Shen T; Chen X; Zhang P; Ling W
Redox Biol; 2019 Feb; 21():101068. PubMed ID: 30684890
[TBL] [Abstract][Full Text] [Related]
2. Activation of the Nrf2-ARE pathway in hepatocytes protects against steatosis in nutritionally induced non-alcoholic steatohepatitis in mice.
Lee LY; Köhler UA; Zhang L; Roenneburg D; Werner S; Johnson JA; Foley DP
Toxicol Sci; 2014 Dec; 142(2):361-74. PubMed ID: 25294219
[TBL] [Abstract][Full Text] [Related]
3. Ezetimibe, an NPC1L1 inhibitor, is a potent Nrf2 activator that protects mice from diet-induced nonalcoholic steatohepatitis.
Lee DH; Han DH; Nam KT; Park JS; Kim SH; Lee M; Kim G; Min BS; Cha BS; Lee YS; Sung SH; Jeong H; Ji HW; Lee MJ; Lee JS; Lee HY; Chun Y; Kim J; Komatsu M; Lee YH; Bae SH
Free Radic Biol Med; 2016 Oct; 99():520-532. PubMed ID: 27634173
[TBL] [Abstract][Full Text] [Related]
4. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
[TBL] [Abstract][Full Text] [Related]
5. Chicoric acid attenuate a nonalcoholic steatohepatitis by inhibiting key regulators of lipid metabolism, fibrosis, oxidation, and inflammation in mice with methionine and choline deficiency.
Kim M; Yoo G; Randy A; Kim HS; Nho CW
Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 27981809
[TBL] [Abstract][Full Text] [Related]
6. Physalin B ameliorates nonalcoholic steatohepatitis by stimulating autophagy and NRF2 activation mediated improvement in oxidative stress.
Zhang MH; Li J; Zhu XY; Zhang YQ; Ye ST; Leng YR; Yang T; Zhang H; Kong LY
Free Radic Biol Med; 2021 Feb; 164():1-12. PubMed ID: 33388433
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte-specific clusterin overexpression attenuates diet-induced nonalcoholic steatohepatitis.
Park JS; Shim YJ; Kang BH; Lee WK; Min BH
Biochem Biophys Res Commun; 2018 Jan; 495(2):1775-1781. PubMed ID: 29229391
[TBL] [Abstract][Full Text] [Related]
8. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
[TBL] [Abstract][Full Text] [Related]
9. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model.
Shimozono R; Asaoka Y; Yoshizawa Y; Aoki T; Noda H; Yamada M; Kaino M; Mochizuki H
Mol Pharmacol; 2013 Jul; 84(1):62-70. PubMed ID: 23592516
[TBL] [Abstract][Full Text] [Related]
10. Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin.
Yang W; Liu L; Wei Y; Fang C; Liu S; Zhou F; Li Y; Zhao G; Guo Z; Luo Y; Li L
Lab Invest; 2021 Mar; 101(3):369-380. PubMed ID: 33268842
[TBL] [Abstract][Full Text] [Related]
11. Gliptins Suppress Inflammatory Macrophage Activation to Mitigate Inflammation, Fibrosis, Oxidative Stress, and Vascular Dysfunction in Models of Nonalcoholic Steatohepatitis and Liver Fibrosis.
Wang X; Hausding M; Weng SY; Kim YO; Steven S; Klein T; Daiber A; Schuppan D
Antioxid Redox Signal; 2018 Jan; 28(2):87-109. PubMed ID: 28635324
[TBL] [Abstract][Full Text] [Related]
12. Aloin protects mice from diet-induced non-alcoholic steatohepatitis via activation of Nrf2/HO-1 signaling.
Xu Q; Fan Y; Loor JJ; Liang Y; Lv H; Sun X; Jia H; Xu C
Food Funct; 2021 Jan; 12(2):696-705. PubMed ID: 33410857
[TBL] [Abstract][Full Text] [Related]
13. Green tea extract provides extensive Nrf2-independent protection against lipid accumulation and NFκB pro- inflammatory responses during nonalcoholic steatohepatitis in mice fed a high-fat diet.
Li J; Sapper TN; Mah E; Rudraiah S; Schill KE; Chitchumroonchokchai C; Moller MV; McDonald JD; Rohrer PR; Manautou JE; Bruno RS
Mol Nutr Food Res; 2016 Apr; 60(4):858-70. PubMed ID: 26679056
[TBL] [Abstract][Full Text] [Related]
14. The indole derivative NecroX-7 improves nonalcoholic steatohepatitis in ob/ob mice through suppression of mitochondrial ROS/RNS and inflammation.
Chung HK; Kim YK; Park JH; Ryu MJ; Chang JY; Hwang JH; Lee CH; Kim SH; Kim HJ; Kweon GR; Kim KS; Shong M
Liver Int; 2015 Apr; 35(4):1341-53. PubMed ID: 25443620
[TBL] [Abstract][Full Text] [Related]
15. Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function.
Upadhyay KK; Jadeja RN; Vyas HS; Pandya B; Joshi A; Vohra A; Thounaojam MC; Martin PM; Bartoli M; Devkar RV
Redox Biol; 2020 Jan; 28():101314. PubMed ID: 31514051
[TBL] [Abstract][Full Text] [Related]
16. Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor.
Ka SO; Bang IH; Bae EJ; Park BH
FASEB J; 2017 Sep; 31(9):3999-4010. PubMed ID: 28536120
[TBL] [Abstract][Full Text] [Related]
17. Genetic Nrf2 Overactivation Inhibits the Deleterious Effects Induced by Hepatocyte-Specific c-met Deletion during the Progression of NASH.
Ramadori P; Drescher H; Erschfeld S; Fragoulis A; Kensler TW; Wruck CJ; Cubero FJ; Trautwein C; Streetz KL; Kroy DC
Oxid Med Cell Longev; 2017; 2017():3420286. PubMed ID: 28676836
[TBL] [Abstract][Full Text] [Related]
18. Exogenous Liposomal Ceramide-C6 Ameliorates Lipidomic Profile, Energy Homeostasis, and Anti-Oxidant Systems in NASH.
Zanieri F; Levi A; Montefusco D; Longato L; De Chiara F; Frenguelli L; Omenetti S; Andreola F; Luong TV; Massey V; Caballeria J; Fondevila C; Shanmugavelandy SS; Fox T; Mazza G; Argemi J; Bataller R; Cowart LA; Kester M; Pinzani M; Rombouts K
Cells; 2020 May; 9(5):. PubMed ID: 32429478
[TBL] [Abstract][Full Text] [Related]
19. Exosomes derived from human umbilical cord mesenchymal stem cells ameliorate experimental non-alcoholic steatohepatitis via Nrf2/NQO-1 pathway.
Kang Y; Song Y; Luo Y; Song J; Li C; Yang S; Guo J; Yu J; Zhang X
Free Radic Biol Med; 2022 Nov; 192():25-36. PubMed ID: 36096356
[TBL] [Abstract][Full Text] [Related]
20. β
Drescher HK; Schippers A; Clahsen T; Sahin H; Noels H; Hornef M; Wagner N; Trautwein C; Streetz KL; Kroy DC
J Hepatol; 2017 Jun; 66(6):1251-1264. PubMed ID: 28192190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
